Delcath Systems, Inc. (DCTH)
$15.36+2.13%Close
SELLBEAR · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $530M
- Beta
- 0.60
- P/E (TTM)
- 1400.91
- Short % float
- 6.81%
- Days to cover
- 5.4
- SI change
- -15.8%
- 1W
- +1.52%
- 1M
- -2.78%
- vs SPY 1W
- +0.36%
- vs SPY 1M
- -5.78%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on DCTH?
- LOPJLB’s latest quantitative signal on Delcath Systems, Inc. (DCTH) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is DCTH in?
- Delcath Systems, Inc. (DCTH) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Delcath Systems, Inc. (DCTH) do?
- Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially red…